Delivery Order SPE2DB22D1106-SPE2DB25FFEM1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.46 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.01 to AmerisourceBergen Drug Corp on August 15, 2025, for Yuvafem 10 micrograms vaginal insert (18 units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction within the federal pharmaceutical supply chain. The contract is set to complete by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 MCG Vaginal Insert (8-count package) with a ceiling value of $2,555.17 under a firm fixed-price contract. This is a non-set-aside award issued as a delivery order, representing a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,285.96 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.84 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, which was not set-aside, represents a routine pharmaceutical procurement under the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEM1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded orders demonstrates its capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/20/25 |